Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival.

We investigated the mechanism by which B lymphocyte stimulator (BLyS)/BAFF, a tumor necrosis factor superfamily ligand, promotes B-cell survival and resistance to atrophy. BLyS stimulation activates 2 independent signaling pathways, Akt/mTOR and Pim 2, associated with cell growth and survival. BLyS blocks the cell volume loss (atrophy) that freshly isolated B cells normally undergo when maintained in vitro while concurrently increasing glycolytic activity and overall metabolism. This atrophy resistance requires Akt/mTOR. We used a genetic approach to resolve the contributions of Akt/mTOR and Pim kinase pathways to BLyS-mediated survival. Pim 2-deficient B cells are readily protected from death by BLyS stimulation, but this protection is completely abrogated by treatment with the mTOR inhibitor rapamycin. Furthermore, rapamycin treatment in vivo significantly reduces both follicular and marginal zone B cells in Pim-deficient but not healthy hosts. BLyS-dependent survival requires the antiapoptotic protein Mcl-1. Mcl-1 protein levels rise and fall in response to BLyS addition and withdrawal, respectively, and conditional deletion of the Mcl-1 gene renders B cells refractory to BLyS-mediated protection. Because BlyS is required for the normal homeostasis of all B cells, these data suggest a therapeutic strategy simultaneously inhibiting mTOR and Pim 2 could target pathogenic B cells.

[1]  A. Edinger.  Controlling cell growth and survival through regulated nutrient transporter expression. , 2007, The Biochemical journal.

[2]  C. Mackay,et al.  BAFF and MyD88 signals promote a lupuslike disease independent of T cells , 2007, The Journal of experimental medicine.

[3]  G. Gores,et al.  Serine 64 Phosphorylation Enhances the Antiapoptotic Function of Mcl-1* , 2007, Journal of Biological Chemistry.

[4]  D. Sabatini,et al.  Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. , 2007, Blood.

[5]  J. Rathmell,et al.  Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. , 2007, Molecular biology of the cell.

[6]  A. Tarakhovsky,et al.  BAFF controls B cell metabolic fitness through a PKCβ- and Akt-dependent mechanism , 2006, The Journal of experimental medicine.

[7]  M. Denning,et al.  The Protein Kinase Cδ Catalytic Fragment Targets Mcl-1 for Degradation to Trigger Apoptosis* , 2006, Journal of Biological Chemistry.

[8]  J. Qin,et al.  SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.

[9]  G. Widhopf,et al.  Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. , 2006, Immunity.

[10]  K. Rajewsky,et al.  Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. , 2006, Immunity.

[11]  D. Sabatini,et al.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.

[12]  D. Green,et al.  Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. , 2006, Molecular cell.

[13]  E. Clark,et al.  BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway , 2005, The Journal of experimental medicine.

[14]  Craig B. Thompson,et al.  Fuel feeds function: energy metabolism and the T-cell response , 2005, Nature Reviews Immunology.

[15]  C. Thompson,et al.  The survival kinases Akt and Pim as potential pharmacological targets. , 2005, The Journal of clinical investigation.

[16]  K. Rajewsky,et al.  c-Myb is critical for B cell development and maintenance of follicular B cells. , 2005, Immunity.

[17]  S. Korsmeyer,et al.  Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Yu-Lung Lau,et al.  Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis. , 2005, International immunology.

[19]  A. Kraft,et al.  Pim Family Kinases Enhance Tumor Growth of Prostate Cancer Cells , 2005, Molecular Cancer Research.

[20]  Lin Chen,et al.  Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. , 2005, Genes & development.

[21]  P. Hammerman,et al.  Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. , 2005, Blood.

[22]  S. Kalled.  The role of BAFF in immune function and implications for autoimmunity , 2005, Immunological reviews.

[23]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[24]  P. Hammerman,et al.  The Pim kinases control rapamycin-resistant T cell survival and activation , 2005, The Journal of experimental medicine.

[25]  S. Grey,et al.  The BAFF/APRIL system: an important player in systemic rheumatic diseases. , 2005, Current directions in autoimmunity.

[26]  D. Jelinek,et al.  Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors. , 2005, Current directions in autoimmunity.

[27]  P. Hammerman,et al.  Lymphocyte Transformation by Pim-2 Is Dependent on Nuclear Factor-κB Activation , 2004, Cancer Research.

[28]  T. Habermann,et al.  Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. , 2004, Blood.

[29]  E. C. Snow,et al.  Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. , 2004, Immunity.

[30]  A. Tarakhovsky,et al.  Regulation of B-cell survival by BAFF-dependent PKCδ-mediated nuclear signalling , 2004, Nature.

[31]  J. Kutok,et al.  TNF Family Member B Cell-Activating Factor (BAFF) Receptor-Dependent and -Independent Roles for BAFF in B Cell Physiology1 , 2004, The Journal of Immunology.

[32]  Sambasiva P Rao,et al.  B Cell-Activating Factor Belonging to the TNF Family Acts through Separate Receptors to Support B Cell Survival and T Cell-Independent Antibody Formation , 2004, The Journal of Immunology.

[33]  Douglas R. McDonald,et al.  RIP Links TLR4 to Akt and Is Essential for Cell Survival in Response to LPS Stimulation , 2004, The Journal of experimental medicine.

[34]  S. Tangye,et al.  The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. , 2004, Current opinion in pharmacology.

[35]  J. Plate.  PI3-Kinase Regulates Survival of Chronic Lymphocytic Leukemia B-Cells by Preventing Caspase 8 Activation , 2004, Leukemia & lymphoma.

[36]  P. Hammerman,et al.  Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  T. Phan,et al.  Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. , 2004, Immunity.

[38]  R. Kimberly,et al.  Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI. , 2004, Arthritis and rheumatism.

[39]  A. Hoffmann,et al.  Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Xiao-Ming Yin,et al.  Degradation of Mcl-1 by Granzyme B , 2004, Journal of Biological Chemistry.

[41]  E. Schattner,et al.  Lymphoma B Cells Evade Apoptosis through the TNF Family Members BAFF/BLyS and APRIL. , 2004, The Journal of Immunology.

[42]  K. Tarte,et al.  BAFF and APRIL protect myeloma cells from apoptosis induced by IL-6 deprivation and dexamethasone , 2003 .

[43]  J. Cyster,et al.  Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. , 2004, Immunity.

[44]  M. Trescol-Biémont,et al.  Regulation of A1/Bfl-1 expression in peripheral splenic B cells. , 2004, Biochimie.

[45]  D. Lawrence,et al.  APRIL-Deficient Mice Have Normal Immune System Development , 2004, Molecular and Cellular Biology.

[46]  R. Bram,et al.  BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells , 2004, The Journal of experimental medicine.

[47]  P. Hammerman,et al.  Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation. , 2004, Cancer research.

[48]  S. Korsmeyer,et al.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1 , 2003, Nature.

[49]  P. Schneider,et al.  BAFF AND APRIL: a tutorial on B cell survival. , 2003, Annual review of immunology.

[50]  V. Roschke,et al.  Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. , 2003, Arthritis and rheumatism.

[51]  M Zweyer,et al.  The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27Kip1 and control of cyclin D1 expression , 2003, Leukemia.

[52]  L. Chodosh,et al.  The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. , 2003, Genes & development.

[53]  I. Maclennan,et al.  NF-κB1 p50 Is Required for BLyS Attenuation of Apoptosis but Dispensable for Processing of NF-κB2 p100 to p52 in Quiescent Mature B Cells1 , 2003, The Journal of Immunology.

[54]  M. Cancro,et al.  Cutting Edge: B Cell Receptor Signals Regulate BLyS Receptor Levels in Mature B Cells and Their Immediate Progenitors 1 , 2003, The Journal of Immunology.

[55]  D. Conrad,et al.  The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. , 2003, Cancer research.

[56]  T. Riccobene,et al.  Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[57]  R. Offringa,et al.  Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression. , 2003, Blood.

[58]  P. Valdez,et al.  Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. , 2003, Immunity.

[59]  I. Maclennan,et al.  NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells. , 2003, Journal of immunology.

[60]  A. Strasser,et al.  B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-kappaB regulated c-myc transcription. , 2002, Molecular cell.

[61]  D. Seshasayee,et al.  BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. , 2002, Immunity.

[62]  C. Thompson,et al.  Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. , 2002, Molecular biology of the cell.

[63]  D. Hilbert,et al.  Cutting Edge: BLyS Enables Survival of Transitional and Mature B Cells Through Distinct Mediators1 , 2002, The Journal of Immunology.

[64]  C. Thompson,et al.  Homeostatic control of lymphocyte survival: potential origins and implications , 2002, Nature Immunology.

[65]  A. Rolink,et al.  BAFFled B cells survive and thrive: roles of BAFF in B-cell development. , 2002, Current opinion in immunology.

[66]  R. Craig.  MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis , 2002, Leukemia.

[67]  S. Chen‐Kiang,et al.  Mechanism of BLyS action in B cell immunity. , 2002, Cytokine & growth factor reviews.

[68]  M. Gold,et al.  CD40 Signaling in B Cells Regulates the Expression of the Pim-1 Kinase Via the NF-κB Pathway1 , 2002, The Journal of Immunology.

[69]  M. Gold,et al.  CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway. , 2002, Journal of immunology.

[70]  Hong-shan Wang,et al.  BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. , 2002, Nature immunology.

[71]  J. Tschopp,et al.  The molecular architecture of the TNF superfamily. , 2002, Trends in biochemical sciences.

[72]  J. Tschopp,et al.  Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. , 2002, The Journal of clinical investigation.

[73]  C. Thompson,et al.  IL-7 Enhances the Survival and Maintains the Size of Naive T Cells1 , 2001, The Journal of Immunology.

[74]  David R. Plas,et al.  Growth Factors Can Influence Cell Growth and Survival through Effects on Glucose Metabolism , 2001, Molecular and Cellular Biology.

[75]  M. Scott,et al.  An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway , 2001, Science.

[76]  J. Tschopp,et al.  BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF , 2001, Science.

[77]  S. Dillon,et al.  TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. , 2001, Immunity.

[78]  H. Perlman,et al.  Constitutively Activated Akt-1 Is Vital for the Survival of Human Monocyte-Differentiated Macrophages , 2001, The Journal of experimental medicine.

[79]  A. Look,et al.  Downregulation of Bim, a Proapoptotic Relative of Bcl-2, Is a Pivotal Step in Cytokine-Initiated Survival Signaling in Murine Hematopoietic Progenitors , 2001, Molecular and Cellular Biology.

[80]  R. Rickert,et al.  CD19-dependent Activation of Akt Kinase in B-lymphocytes* , 2001, The Journal of Biological Chemistry.

[81]  G. Alarcón,et al.  Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus Erythematosus1 , 2001, The Journal of Immunology.

[82]  P. Moore,et al.  Synthesis and release of B-lymphocyte stimulator from myeloid cells. , 2001, Blood.

[83]  M. Tourigny,et al.  Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response , 2000, The Journal of experimental medicine.

[84]  T. Kadowaki,et al.  Phosphatidylinositol 3-Kinase and NF-κB/Rel Are at the Divergence of CD40-Mediated Proliferation and Survival Pathways , 2000, The Journal of Immunology.

[85]  S. Edwards,et al.  Functional analysis of the human MCL-1 gene , 2000, Cellular and Molecular Life Sciences CMLS.

[86]  A. Strasser,et al.  Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. , 1999, Science.

[87]  Min-Liang Kuo,et al.  The Antiapoptotic Gene mcl-1 Is Up-Regulated by the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway through a Transcription Factor Complex Containing CREB , 1999, Molecular and Cellular Biology.

[88]  J. Tschopp,et al.  BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth , 1999, The Journal of experimental medicine.

[89]  R. Hardy,et al.  c‐Rel is essential for B lymphocyte survival and cell cycle progression , 1998, European journal of immunology.

[90]  R. Craig,et al.  Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. , 1997, Blood.

[91]  S. Korsmeyer,et al.  Regulation of B cell survival in xid mice by the proto-oncogene bcl-2. , 1996, Journal of immunology.

[92]  S. Korsmeyer,et al.  Radiation-induced apoptosis is differentially regulated in primary B cells from normal mice and mice with the CBA/N X-linked immunodeficiency. , 1995, Journal of immunology.

[93]  P. Laird,et al.  Mouse model systems to study multistep tumorigenesis. , 1994, Cold Spring Harbor symposia on quantitative biology.

[94]  P. Laird,et al.  Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells. , 1993, Blood.

[95]  S. Korsmeyer,et al.  bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.